ABBOTT LABORATORIES ABT revenue by segment, product and geography
In its fiscal year ending 2025-12-31, ABBOTT LABORATORIES reported revenue across 9 geographies; the largest, Outside the United States, was $27.2B (+6.1% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Outside the United States$27.2Bshare n/a+6.1% yoy
- United States$17.1Bshare n/a+4.9% yoy
- All Other Countries$16Bshare n/a+8.1% yoy
- Germany$2.76Bshare n/a+8.7% yoy
- China$1.91Bshare n/a-9.7% yoy
- Switzerland$1.87Bshare n/a+7.1% yoy
- India$1.87Bshare n/a+3.0% yoy
- Japan$1.48Bshare n/a+2.4% yoy
- +1 more member in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- Outside the United States$7.38B58.6%+7.4% yoy
- United States$5.22B41.4%+22.0% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.